Beyond funding, McKesson Amplify also will provide resources, strategic support and other tools to help state pharmacy ...

McKesson Amplify is intended to help protect critical pharmacy services and elevate the profession by strengthening the voice ...

McKesson has launched McKesson Amplify, a strategic initiative intended to help protect critical pharmacy services and elevate the pharmacy profession by strengthening the voice of the ...

International Assets Investment Management LLC lessened its stake in McKesson Co. (NYSE:MCK – Free Report) by 99.8% in the ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on McKesson (MCK – Research Report), with a price target of ...

McKesson (NYSE:MCK – Free Report) had its price objective decreased by Bank of America from $680.00 to $650.00 in a report ...

The transaction enables McKesson to focus capital deployment and prioritize investments in strategic oncology and biopharma ...

Seeks ideas for investing fiscal year 2026 opioid settlement funds The Wisconsin Department of Health Services (DHS) awarded agencies in communities across the state more than $21 million from the ...

MCK aims to focus on capital deployment and prioritize investments to strengthen its strategic oncology and biopharma growth platforms.

Kairos Pharma Ltd. , a clinical-stage biopharmaceutical company, announced today that John S. Yu, M.D., Chief Executive Officer, and Neil Bhowmick, Chief Scientific Officer, will present a corporate ...

Toronto-based private equity firm Birch Hill Equity Partners has completed its acquisition of the Rexall Pharmacy Group.